TPMG seeks participants for COVID-19 oral drug research study

TPMG’s Clinical Research Division in Williamsburg is seeking participants for a study of an oral drug that could help prevent COVID-19 (Photo by Karolina Grabowska of Pexels)

WILLIAMSBURG – The clinical research division of the Tidewater Physicians Multispecialty Group (TPMG) in Williamsburg is seeking participants for a research study regarding an oral drug that could be used as a possible preventative for COVID-19 in households where a person has recently tested positive for the virus.

An Oct. 6 press release from TPMG says the trial will study the effectiveness of the oral drug made by Merck, Molnupiravir, and its preventative effect for household members who live near someone who tests positive for COVID- 19.

Participants will participate in a placebo-controlled study, which means that those involved in the trial will have a 50 percent chance of receiving the drug or control. The pill will be taken by participants twice a day for five days.

“We are doing something to try to help people who cannot get vaccinated,” said Vijay Subramaniam, director of clinical research for TPMG Williamsburg, MD, FCCP.

Dr Subramaniam is also the principal investigator during the trial.

if approved by the Food and Drug Administration (FDA) and other relevant regulatory agencies, molnupiravir would be the first oral antiviral drug used to prevent the transmission of COVID-19.

To qualify, participants must meet the following criteria:

  • 18 years or older
  • Live with only one person (no age requirement) who has tested positive for COVID-19 or any laboratory-confirmed history of infection
  • Must not have received the COVID-19 vaccine

TPMG notes that vaccination remains the safest and most effective way to prevent COVID-19. The trial of this drug aims to provide prevention and protection for those who do not or cannot receive the COVID-19 vaccine.

To learn more or to see if you qualify, call (757) 707-3503 or email [email protected]

To make an appointment to receive a COVID-19 vaccine, contact your health care provider or visit the Vaccinate Virginia website.

Always be informed. Click here to get the latest news and information delivered to your inbox

Source link

Leave A Reply

Your email address will not be published.